Sep 22, 2021 @ 14:38
DOJ monitoring Senate probe into Pharmally deal – Guevarra
The Department of Justice is closely monitoring the Senate blue ribbon committee hearings on the controversial government pandemic procurements which implicated personalities maintaining close ties with President Duterte.
“The usual practice is that the blue ribbon committee completes its investigation and furnishes the DOJ or the OMB (Ombudsman) a copy of its report for further criminal investigation and prosecution. But we monitor the senate proceedings whenever our time permits, ” Guevarra said in a message.
The powerful Senate committee has been conducting hearings on alleged irregularities surrounding COVID-19 supplies such as PPEs, face shields, and face masks.
Over the course of the probe, Michael Yang has been revealed as the alleged financier and guarantor of the controversial Pharmally Pharmaceutical Corporation.
Despite the alleged anomalies, President Duterte continues to absolve Yang – an old friend and his former economic adviser – from any wrongdoing.
He criticized senators conducting the probe into Pharmally and insisted that there was nothing anomalous in the deals.
In a recent testimony, two Pharmally executives said Yang personally loaned money to help the trading firm pay Chinese companies for medical supplies ordered by the Philippine government—belying Yang’s claim that he only introduced a Pharmally director to his friends among suppliers in China and had no role in the transactions.
Pharmally was awarded over P8 billion worth of COVID-19 contracts in 2020 even if the small firm lacked the track record and credibility to engage in big ticket government procurement. In 2021, it got contracts worth P2.3 billion.